{"id":"NCT00824473","sponsor":"Meda Pharmaceuticals","briefTitle":"A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies","officialTitle":"Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 in Subjects With Seasonal Allergic Rhinitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-12","primaryCompletion":"2009-02","completion":"2009-02","firstPosted":"2009-01-16","resultsPosted":"2010-01-28","lastUpdate":"2010-02-23"},"enrollment":506,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Seasonal Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"0.15% azelastine hydrochloride","otherNames":[]}],"arms":[{"label":"1","type":"PLACEBO_COMPARATOR"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine if one allergy medication (0.15% azelastine hydrochloride) is more effective than Placebo alone","primaryOutcome":{"measure":"Change From Baseline in 12-hour Reflective Total Nasal Symptom Score(rTNSS)for the Entire 14-day Study Period Compared to Placebo (AM and PM Combined)at 14 Days","timeFrame":"baseline and 14 days","effectByArm":[{"arm":"Placebo","deltaMin":18.76,"sd":3.301},{"arm":"Astepro 0.15%","deltaMin":18.48,"sd":3.231}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":7,"countries":["United States"]},"refs":{"pmids":["22287431"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":255},"commonTop":["Nasal discomfort","Dysgeusia","Headache","Sneezing"]}}